Study finds no benefit, higher death rate in patients taking malaria drug for COVID-19

A malaria drug widely touted by President Donald Trump for treating the new coronavirus showed no benefit in a large analysis of its use in U.S. veterans hospitals. There were more deaths among those given hydroxychloroquine versus standard care, researchers reported.

More Stories from the News Network

The New Mexico News Network is a service of the New Mexico Broadcasters Association. 

Latest News

Latest Releases